Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2021-05-06 Capital/Financing Update
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Appendix 3G ($0.02 options exp. May 23) 12 pages 252.5KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3G Notification of issue, conversion or payment up of equity +securities' and is addressed to the ASX (Australian Securities Exchange). It details the issuance of new securities, specifically unlisted options over ordinary shares, including the number of securities issued, their terms, and the context of issuance (variation of Secured Convertible Notes approved by shareholders). The document is a formal notification of a capital change event, specifically the issuance of new equity securities. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about a capital/financing activity. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2021-05-06 English
Appendix 3G ($0.03 options exp. May 23) 12 pages 252.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form, which is a notification to the ASX (Australian Securities Exchange) regarding the issue, conversion, or payment up of equity securities. It includes detailed information about the securities issued, their type, number, and purpose. This type of filing is a regulatory announcement about capital changes, specifically the issuance of new securities. It is not a full financial report, earnings release, or management discussion. It is a formal notification of a capital change event, consistent with announcements about share issues or capital structure changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is the actual notification, not just an announcement of a report or a certification.
2021-05-06 English
Appendix 3G ($0.04 options exp. May 23) 12 pages 252.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form submitted to the ASX, which is a notification of the issue, conversion, or payment up of equity securities. It includes detailed information about the securities issued, their type, number, and purpose. The document is regulatory in nature, specifically notifying the market and the ASX about new securities issued by the company. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital change event. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is the announcement itself, not just a brief notice or a report publication announcement.
2021-05-06 English
Appendix 3G ($0.03 options exp. Oct 22) 12 pages 253.5KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3G form, which is a notification to the ASX (Australian Securities Exchange) regarding the issue, conversion, or payment up of equity securities. It details the type and number of securities issued, the purpose of the issue, and references shareholder approval at an Extraordinary General Meeting (EGM). This type of document is a regulatory announcement about capital changes, specifically the issuance of new securities, rather than a full financial report or earnings release. It is not an annual or interim report, audit report, or earnings release. It is also not a proxy statement, voting results, or management information. The document fits the category of a capital or financing update as it informs the market about changes in the company's capital structure through the issuance of new securities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2021-05-06 English
Adherium response to Respiri announcement 1 page 16
M&A Activity Classification · 95% confidence The document is a formal announcement from Adherium Limited regarding a takeover bid by Respiri Limited. It advises shareholders to take no action until the board makes a formal recommendation. The content focuses on a merger/acquisition activity, specifically a takeover offer, and the company's response to it. The document is not a full report, financial statement, or regulatory filing but an announcement related to M&A activity.
2021-04-29 English
EGM presentation 10 pages 1.9MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated April 2021 from Adherium, focusing on the company's strategy, market opportunity, product development, and commercial progress in the respiratory remote digital monitoring environment. It includes forward-looking statements, market analysis, product roadmap, and fundraising plans. There are no financial statements, audit opinions, or regulatory certifications present. The content is structured as a comprehensive investor or business presentation highlighting strategy, market trends, and product evolution rather than a formal financial report or regulatory filing. Therefore, the document best fits the category of an Investor Presentation (IP).
2021-04-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.